News
CYTO
2.350
-2.89%
-0.070
Health Care Sector Update for 03/25/2024: SINT, MASI, LABP, ABBV, CYTO
NASDAQ · 2d ago
Nasdaq Turns Higher; Akanda Shares Plunge
U.S. Stocks traded mixed toward the end of trading on Monday. The Dow traded down 0.37% while the Nasdaq Composite turned higher. Energy shares jumped by 1% on Monday; industrials shares fell by 0.5%. Sales of new single-family houses in the U.S., fell by 662,000 in February. Asian markets closed lower; European shares mostly higher.
Benzinga · 2d ago
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Landos Biopharma, Inc. Shares jumped 171.2% to $21.70 on Monday. AbbVie and Landos signed a definitive agreement to acquire the company. Altamira Therapeutics Ltd. Shares climbed 70.1% after falling around 22% on Friday. GameStop Corp. Shares rose 8.4% after the company announced a separation.
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Landos Biopharma (NASDAQ:LABP) shares rose 173.9% to $21.45 during Monday's regular session. The company's, Q4 earnings report came out 2 days ago. Sagimet Biosciences ( NASDAQ:SGMT) and XTL Biopharmaceuticals also moved upwards. Trxade Health stock decreased by 48.6% during the regular session to $12.38.
Benzinga · 2d ago
Altamira stock rallies 44% on Univercells mRNA collaboration
Seeking Alpha · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Wall Street's main indexes open lower on Monday. Dow Jones Industrial Average was down 0.26% at 39,373.11. Boeing gained after the planemaker said its CEO would be stepping down. Landos Biopharma, Foot Locker, US energy sector rise.
Reuters · 2d ago
Crude Oil Moves Higher; US New Home Sales Fall In February
U.S. Stocks traded lower midway through trading on Monday. The Dow Jones index fell more than 100 points. Energy shares jumped by 1% on Monday; communication services shares fell by 0.5%. Sales of new single-family houses in the U.S., fell by 662,000 in February. Asian markets closed lower in Asia Pacific markets.
Benzinga · 2d ago
Why Altamira Therapeutics Stock Is Racing Higher
Altamira Therapeutics has entered into a collaboration agreement with Univercells Group to evaluate the delivery of mRNA vaccines. Altamira shares are climbing on heavy trading volume following the announcement. The company does not pay a dividend but has a few ways to return value to shareholders.
Benzinga · 2d ago
Nkarta, Nuvation Bio, Canopy Growth among healthcare movers
Nkarta, Nuvation Bio, Canopy Growth among healthcare movers. S&P 500 Health Care Sector +0.1% to $1,699.17. Pharmaceuticals, Biotechnology & Life Science contributes 0.5% to index.
Seeking Alpha · 3d ago
US Stocks Down; Chicago Fed National Activity Index Rises In February
U.S. Stocks traded lower on Monday, with the Dow Jones index falling more than 50 points. Energy shares jumped by 1.3% on Monday. The Chicago Fed National Activity Index rose to a three-month high level of 0.05 in February. Asian markets closed lower in Asia Pacific markets.
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Landos Biopharma (NASDAQ:LABP) shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. Altamira Therapeutics shares rose 49.71% after their Q4 earnings report came out yesterday. Neuronetics stock increased by 18.19% in pre- market.
Benzinga · 3d ago
Weekly Report: what happened at CYTO last week (0318-0322)?
Weekly Report · 3d ago
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
Altamira Therapeutics Ltd. Has entered into a collaboration agreement with Univercells Group to evaluate the use of the Company's platform for the delivery of mRNA vaccines. The company is a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets.
Barchart · 3d ago
Weekly Report: what happened at CYTO last week (0311-0315)?
Weekly Report · 03/18 12:28
Weekly Report: what happened at CYTO last week (0304-0308)?
Weekly Report · 03/11 12:23
Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers
Healthcare On the Move Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers. S&P 500 Health Care Sector +0.12% to 1704.79. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 03/04 15:00
Weekly Report: what happened at CYTO last week (0226-0301)?
Weekly Report · 03/04 12:28
12 Health Care Stocks Moving In Friday's Intraday Session
Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 58.8% to $3.24 during Friday's regular session. The company's market cap stands at $73.3 million. BioVie (NASdaq:BIVI) shares moved upwards by 48.38% in the same session. Altamira Therapeutics and MSP Recovery also gained.
Benzinga · 03/01 17:34
Weekly Report: what happened at CYTO last week (0219-0223)?
Weekly Report · 02/26 12:48
Weekly Report: what happened at CYTO last week (0212-0216)?
Weekly Report · 02/19 12:51
More
Webull provides a variety of real-time CYTO stock news. You can receive the latest news about Altamira Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CYTO
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell growth and proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.